Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.6100
-0.0059 (-0.96%)
At close: Oct 13, 2025, 4:00 PM EDT
0.6100
0.00 (0.00%)
After-hours: Oct 13, 2025, 6:30 PM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $7.33 million as of October 13, 2025. Its market cap has decreased by -72.39% in one year.
Market Cap
7.33M
Enterprise Value
29.23M
1-Year Change
-72.39%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has decreased from $34.49M to $7.33M, a decrease of -78.74%. That is a compound annual growth rate of -76.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 7.50M | -55.01% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |